01Active phase: Scientific strategy
Scientific strategy
Medical and scientific input into the regulatory route and key evidence questions.
Discuss this phase →
05 / Regulatory & scientific
Scientific clarity for difficult regulatory decisions.
Support regulatory strategy with evidence summaries, benefit-risk reasoning and robust scientific justification, particularly where categories or classifications are not straightforward.
05
Senior-led
Medical Affairs
DECISION → EVIDENCE → ACTION
About this service
Scientific reasoning for difficult category decisions
Support regulatory strategy with evidence summaries, benefit-risk reasoning and robust scientific justification, particularly where categories or classifications are not straightforward.
A product sits near a medicine, supplement or device boundary, or a submission needs stronger scientific reasoning.
Built for
Regulatory Affairs
R&D leads
Innovation teams
Medical Affairs
“Bring the evidence, product category and regulatory route into one view.”
What we deliver
Focused outputs, built for the next decision.
Senior scientific input is translated into clear, usable outputs for cross-functional teams.
01
Scientific strategy
Medical and scientific input into the regulatory route and key evidence questions.
02
Evidence summaries
Decision-ready reviews for submission packages and internal governance.
03
Classification support
Structured scientific reasoning for medicines, supplements and consumer devices.
04
Regulator responses
Scientific support for questions, clarifications and evidence requests.
Commercial impact
Senior judgement that leaves the next decision clearer.
The value is not more process. It is a proportionate scientific route, fewer late surprises and outputs that cross-functional teams can use.
✓ Direct, decision-ready support for regulatory affairs.
✓ Direct, decision-ready support for r&d leads.
✓ Direct, decision-ready support for innovation teams.
✓ Direct, decision-ready support for medical affairs.
How we work together.
A focused, senior-led route from the first question to a practical output your team can use.
02Active phase: Evidence summaries
Evidence summaries
Decision-ready reviews for submission packages and internal governance.
Discuss this phase →
03Active phase: Classification support
Classification support
Structured scientific reasoning for medicines, supplements and consumer devices.
Discuss this phase →
FAQ
Questions about this service.
What does this service cover?
Scientific strategy, Evidence summaries, Classification support, Regulator responses. Scope is tailored to the decision and evidence available.
Can this be commissioned as a focused project?
Yes. It can be a defined project or connected into retained senior medical affairs support.
Who leads the work?
Every engagement is senior-led, with direct access to the person shaping the scientific judgement and recommendation.
Related services
Connect the next part of the pathway.
NP
Consumer Health Innovation & NPD
Shape product opportunities early with scientific, regulatory and medical input.
Explore service →MR
Medical Review & Copy Clearance
Review claims and copy early so the core idea remains evidence-led and approval-ready.
Explore service →MA
Medical Affairs Strategy
Connect evidence priorities, positioning and lifecycle decisions to the commercial plan.
Explore service →